Bardelli A - Search Results

1

Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance.

Ali M, Kaltenbrun E, Anderson GR, Stephens SJ, Arena S, Bardelli A, Counter CM, Wood KC. Ali M, et al. Among authors: bardelli a. Nat Commun. 2017 Jun 8;8:15617. doi: 10.1038/ncomms15617. Nat Commun. 2017. PMID: 28593995 Free PMC article.

2

Identification of cancer genes by mutational profiling of tumor genomes.

Benvenuti S, Arena S, Bardelli A. Benvenuti S, et al. Among authors: bardelli a. FEBS Lett. 2005 Mar 21;579(8):1884-90. doi: 10.1016/j.febslet.2005.02.015. FEBS Lett. 2005. PMID: 15763568 Free article. Review.

3

Genetic analysis of the kinome and phosphatome in cancer.

Arena S, Benvenuti S, Bardelli A. Arena S, et al. Among authors: bardelli a. Cell Mol Life Sci. 2005 Sep;62(18):2092-9. doi: 10.1007/s00018-005-5205-1. Cell Mol Life Sci. 2005. PMID: 16132230 Free PMC article. Review.

4

Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies.

Benvenuti S, Sartore-Bianchi A, Di Nicolantonio F, Zanon C, Moroni M, Veronese S, Siena S, Bardelli A. Benvenuti S, et al. Among authors: bardelli a. Cancer Res. 2007 Mar 15;67(6):2643-8. doi: 10.1158/0008-5472.CAN-06-4158. Cancer Res. 2007. PMID: 17363584

5

Genetic targeting of the kinase activity of the Met receptor in cancer cells.

Arena S, Pisacane A, Mazzone M, Comoglio PM, Bardelli A. Arena S, et al. Among authors: bardelli a. Proc Natl Acad Sci U S A. 2007 Jul 3;104(27):11412-7. doi: 10.1073/pnas.0703205104. Epub 2007 Jun 26. Proc Natl Acad Sci U S A. 2007. PMID: 17595299 Free PMC article.

6

Exposure to the tobacco smoke constituent 4-aminobiphenyl induces chromosomal instability in human cancer cells.

Saletta F, Matullo G, Manuguerra M, Arena S, Bardelli A, Vineis P. Saletta F, et al. Among authors: bardelli a. Cancer Res. 2007 Aug 1;67(15):7088-94. doi: 10.1158/0008-5472.CAN-06-4420. Cancer Res. 2007. PMID: 17671175 Free article.

7

Knock-in of oncogenic Kras does not transform mouse somatic cells but triggers a transcriptional response that classifies human cancers.

Arena S, Isella C, Martini M, de Marco A, Medico E, Bardelli A. Arena S, et al. Among authors: bardelli a. Cancer Res. 2007 Sep 15;67(18):8468-76. doi: 10.1158/0008-5472.CAN-07-1126. Cancer Res. 2007. PMID: 17875685

8

PIK3CA cancer mutations display gender and tissue specificity patterns.

Benvenuti S, Frattini M, Arena S, Zanon C, Cappelletti V, Coradini D, Daidone MG, Pilotti S, Pierotti MA, Bardelli A. Benvenuti S, et al. Among authors: bardelli a. Hum Mutat. 2008 Feb;29(2):284-8. doi: 10.1002/humu.20648. Hum Mutat. 2008. PMID: 18022911

9

Understanding how kinase-targeted therapies work.

Arena S, Bardelli A. Arena S, et al. Among authors: bardelli a. Cell Cycle. 2008 Jun 1;7(11):1560-3. doi: 10.4161/cc.7.11.6031. Epub 2008 Mar 30. Cell Cycle. 2008. PMID: 18469513

10

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.

Di Nicolantonio F, Martini M, Molinari F, Sartore-Bianchi A, Arena S, Saletti P, De Dosso S, Mazzucchelli L, Frattini M, Siena S, Bardelli A. Di Nicolantonio F, et al. Among authors: bardelli a. J Clin Oncol. 2008 Dec 10;26(35):5705-12. doi: 10.1200/JCO.2008.18.0786. Epub 2008 Nov 10. J Clin Oncol. 2008. PMID: 19001320 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

357 results

Search Page